Advantage Alpha Capital Partners LP Dynavax Technologies Corp Transaction History
Advantage Alpha Capital Partners LP
- $299 Million
- Q3 2025
A detailed history of Advantage Alpha Capital Partners LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 25,892 shares of DVAX stock, worth $286,365. This represents 0.09% of its overall portfolio holdings.
Number of Shares
25,892
Previous 31,158
16.9%
Holding current value
$286,365
Previous $309,000
16.83%
% of portfolio
0.09%
Previous 0.09%
Shares
8 transactions
Others Institutions Holding DVAX
# of Institutions
303Shares Held
120MCall Options Held
293KPut Options Held
311K-
Black Rock Inc. New York, NY21.9MShares$242 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.7MShares$174 Million4.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$89.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.29MShares$69.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.53MShares$50.1 Million0.02% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.4B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...